| Subject: |
|
Diabetes, Hypertension and magnesium |
| Name: |
|
Claudia French RN, LPHA |
| Date Posted: |
|
Aug 2, 07 - 5:24 PM |
| IP Address: |
|
97.97.231.127 |
| Email: |
|
cfrench180@tampabay.rr.com |
| Website: |
|
http://MagnesiumForLife: www.magnesiumforlife.com/ |
| Message: |
|
It's amazing to me how much information we have over the past few years on diabetes and magnesium, and they are still saying that we need more "well designed clinical trials" to prove what we already know. There is also plenty on magnesium and hypertension. Still magnesium supplementation is not recognized nor promoted by the American Diabetes Association, despite the fact that studies have shown that at minimum, 80% of diabetics are deficient in magnesium, with 50 % well below even half the recommended daily allowance. Such a simple thing , to add magnesium, which will combat both insulin resistance and hypertension.....and do so much more. All diabetics and all labeled "pre-diabetic" should be supplementing with magnesium. All who have been told they have metabolic syndrome, a precursor to diabetes type 2 should be supplementing with magnesium. All type one diabetics should be supplementing with magnesium, to prevent the resistance that developes and all on weight loss diets to avoid onset of diabetes should be supplementing with magnesium. We simply can no longer rely on diet alone to provide our magnesium needs. Transdermal magnesium is the best and fastest way to increase our magnesium levels. All diabetics should have a good quality magnesium oil and use it frequently!
Here's a recently published article in pubmed.
Magnesium metabolism in hypertension and type 2 diabetes mellitus.
Barbagallo M, Dominguez LJ, Resnick LM.
1Institute of Internal Medicine and Geriatrics, University of Palermo, Italy; and 2Hypertension Center, NY-Presbyterian Hospital/Cornell Medical Center, New York, NY. Am J Ther. 2007 Jul-Aug;14(4):375-85.
The increasing evidence for the clinical relevance of altered magnesium metabolism to states of altered insulin resistance confirms the role of magnesium deficit as a possible underlying common mechanism of the "insulin resistance" of hypertension and altered glucose tolerance. The pioneer work of Lawrence M. Resnick and his group using the cellular ion-based approach that we are only partially presenting here has consistently contributed to the progress of the field, demonstrating (a) the critical importance of magnesium metabolism in regulating insulin sensitivity as well as vascular tone, and blood-pressure homeostasis; (b) that magnesium deficiency, defined on the basis of intracellular free magnesium levels, and or serum ionized magnesium is a common feature of both diabetic and hypertensive states as well as various other cardiovascular and metabolic processes and aging; (c) the ability of environmental factors such as dietary nutrient-sugar and mineral content to alter the set point of steady-state cell ion activity; and (d) that magnesium supplementation is indicated in conditions associated with magnesium deficit although well-designed therapeutic trials of magnesium in essential hypertension and type 2 diabetes mellitus are needed in the near future. |
|
|
|
|
|
|
Reply
Home
bravenet.com